Alligo AB Series B (ALLIGO-B) fair value: what the stock is really worth
As of Oct 20, 2026: fair value (intrinsic value) of Alligo AB Series B stock SEK 103, price SEK 124, upside -16.6%, quality 57 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range kr 69.95 – kr 152.85 · fair‑value band kr 67.19 – kr 138.34 · the kr 123.60 price screens above the kr 103.08 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Follow Alligo AB Series B in your weekly email
Every Wednesday you see whether Alligo AB Series B is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Alligo AB (publ) provides workwear, personal protection, tools, and consumables in Sweden, Norway, and Finland.
Show moreShow less
The company offers personal protective equipment and clothing, such as workwear, shoes, gloves, protective equipment, profile clothing, and accessories; and tools, including machines, hand tools, power tools, and measuring tools, as well as cutting, grinding, and drilling tools.
It also provides oils, chemical products, and automotive and garage products; industry and welding products comprising hydraulics, hoses, and welds; lifting and load securing, equipment, supplies, and other equipment for the workplace; screws, nails, plugs, fittings, and expanders; and flow technology, outdoor products, various equipment and services.
The company offers its products under 1832, 4USE, AmPro, AWARD, Bjornklader, Gesto, INNO, NUAIR, PROWEL, and UNIVERN brands.
It serves fishing and aquaculture, agriculture and forestry, repair and maintenance, transport and storage, oil and gas, public sector, manufacturing, construction, and other industries.
The company was formerly known as Momentum Group AB (publ) and changed its name to Alligo AB (publ) in December 2021. Alligo AB (publ) was founded in 1963 and is headquartered in Stockholm, Sweden.
Stock analysis
Alligo AB Series B (ALLIGO-B) currently trades at kr 123.60, while our model-based Fair Value estimate is kr 103.08, 16.6% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of kr 130.14 per share, and 9 of the 23 models we run sit above the kr 123.60 price.
Bear case: the Earnings-Based group reads lowest at kr 44.25, and 14 of the 23 models stay below the price. Data coverage for this calculation is high.
Scenario range: kr 67.19 (bear) to kr 138.34 (bull), the price of kr 123.60 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Alligo AB Series B reported revenue of 9.6B SEK in FY2025 versus 8.5B SEK in FY2021, a compound +3.0%/yr. Reported net income was 261M SEK in FY2025, compounding −2.7%/yr from FY2021.
Key figures
Market cap 6.2B SEK (≈ $624M) Small · P/E ratio 17.8 · P/S ratio 0.63 · EPS (TTM) kr 6.86 · Dividend yield 1.8% · Net margin 3.5% · Return on equity 9.3% · Return on assets (EBIT) 6.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 34 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 16% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −39% fair-value upside, at −17%, ALLIGO-B screens cheaper than that median.
Fair Value models
Bearkr 67.19Fair Value kr 103.08Bullkr 138.34
Price kr 123.60 · Upside -16.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (kr 3.74 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.63/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+2.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.7%
Start year 2020 (pandemic). Over 10 years: +6.3% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+6.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.9%
Dividend (yield on the price)1.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−2.0% vs 0.6%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 6%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Sweden: IMF forecast 2.0% a year to 2030, 2.9% from 2016 to 2025) that is about +1.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Industrial Distribution · 106 stocks
Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score57 · Below median
Fair Value upside−16.6% · Below median
Profitability
Return on equity (12 months)9.3% · Above median
Return on assets2.7% · Below median
Net margin (12 months)3.5% · Below median
Operating margin (12 months)5.7% · Below median
Growth and dividend
Revenue growth (quarter YoY)5.7% · Above median
Dividend yield (12 months)1.8% · Below median
Balance sheet
Debt / equity0.60× · Highest 25%
Valuation Multiplesvs Industrial Distribution median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Alligo AB Series B Fair Value". https://www.fairvalue-calculator.com/stock/ALLIGO-B
Frequently asked questions
Is Alligo AB Series B (ALLIGO-B) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of kr 103.08 versus a price of kr 123.60, about −17% upside (overvalued).
What is the fair value of ALLIGO-B?
Our model-based fair value for Alligo AB Series B is kr 103.08 (as of Oct 2, 2026), built from audited fundamentals. The current price: kr 123.60.
What is the quality score of ALLIGO-B?
Alligo AB Series B has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Alligo AB Series B (ALLIGO-B)?
Our model-based price target is the fair value of kr 103.08 (as of Oct 2, 2026) from 23 valuation models. Cautious scenario kr 67.19, optimistic scenario kr 138.34. It is a calculation from audited fundamentals, not an analyst target.
What is the Alligo AB Series B stock forecast for 2026?
Our models put fair value at kr 103.08, about −17% upside versus a price of kr 123.60 (overvalued). Cautious scenario kr 67.19, optimistic scenario kr 138.34. The calculation is refreshed regularly with new filings.
What is the revenue of Alligo AB Series B (ALLIGO-B)?
Alligo AB Series B reported trailing-twelve-month revenue of about 9.8B SEK (latest available figure, as of Oct 2, 2026).
Does Alligo AB Series B pay a dividend?
Alligo AB Series B currently shows a dividend yield of 1.78% relative to its recent price (as of Oct 2, 2026).
What growth is priced into Alligo AB Series B (ALLIGO-B)?
For today's price to be fair in a discounted-cash-flow model, Alligo AB Series B would have to grow free cash flow by +3.0 % per year for five years (discount rate 11.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.8 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of ALLIGO-B use?
Our models discount Alligo AB Series B at 11.4 %: a base by market capitalisation (small), damped by beta 1.15, country premium for Sweden. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Alligo AB Series B that is +3.0 % per year a year over ten years, using the same discount rate (11.4 %) and the same formula as our fair value.
How much growth has Alligo AB Series B (ALLIGO-B) delivered so far?
Over the past 5 years revenue at Alligo AB Series B grew +4.8 % a year. The price currently implies +3.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Alligo AB Series B (ALLIGO-B) growing?
The median revenue growth in the sector is +7.5 % a year. That is the yardstick for the growth priced into Alligo AB Series B (+3.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Alligo AB Series B (ALLIGO-B)?
The free-cash-flow yield on the price is 11.25 %: that much free cash flow Alligo AB Series B produces per unit of market value. When it exceeds the discount rate of our models (11.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Alligo AB Series B (ALLIGO-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Alligo AB Series B it is kr 103.08 per share (as of Oct 2, 2026), against a price of kr 123.60. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Alligo AB Series B stock overvalued or undervalued in 2026?
As of Oct 2, 2026, ALLIGO-B trades above its calculated fair value: price kr 123.60, fair value kr 103.08, a gap of about −17% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALLIGO-B?
No. The price is what the market pays today (kr 123.60); the fair value is what the company's own numbers justify (kr 103.08). For Alligo AB Series B the two are kr 20.52 per share apart. That gap is exactly why we show both numbers side by side.
How much is Alligo AB Series B worth?
The market values Alligo AB Series B at about 6.2B SEK (market capitalisation, as of Oct 2, 2026). Per share that is kr 123.60; our models calculate a fair value of kr 103.08 per share.
What do the bullish and bearish scenarios say about ALLIGO-B?
Our models span a range for Alligo AB Series B: cautious scenario kr 67.19, base kr 103.08, optimistic kr 138.34 per share (as of Oct 2, 2026, price kr 123.60). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ALLIGO-B?
Alligo AB Series B trades at a price-to-earnings ratio of 17.8 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 103.08 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 19.7 (reported for FY2025: 23.7). Other multiples: P/B 1.7, P/S 0.6, EV/EBITDA 10.3.
How solid is the balance sheet of Alligo AB Series B (ALLIGO-B)?
Balance-sheet figures for Alligo AB Series B (as of Oct 2, 2026): return on equity 9.3%, debt of 0.60 per unit of equity. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is ALLIGO-B from its 52-week high?
Alligo AB Series B trades at kr 123.60, about 15% below its 52-week high of kr 146.00 and 16% above the low of kr 106.71 (as of Oct 20, 2026). Distance from the high says nothing about value: that is what the fair value of kr 103.08 is for.
Which stocks are comparable to Alligo AB Series B?
From the same area (Industrials) we also value W.W. Grainger, Inc, Fastenal Company, Ferguson Enterprises Inc, WESCO International, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Alligo AB Series B stock attractive at the current price?
The data as of Oct 2, 2026: price kr 123.60, calculated fair value kr 103.08 (−17%), Quality Score 57/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALLIGO-B calculated?
We run Alligo AB Series B through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 103.08, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.8 % above its aggregate fair value. Alligo AB Series B itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Alligo AB Series B (ALLIGO-B)?
The closing price on Oct 20, 2026 was kr 123.60. Our model-based fair value is kr 103.08, about −17% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Alligo AB Series B right now?
Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (kr 67.19 to kr 138.34) leaves room in how you read the outcome.
Where does the earnings growth of Alligo AB Series B (ALLIGO-B) come from?
Earnings per share at Alligo AB Series B grew +6.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +0.0 %, EBIT margin +9.2 %, tax rate +0.0 %, residual (interest, one-offs) −2.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Alligo AB Series B
How large is the market capitalisation of Alligo AB Series B (ALLIGO-B)?
The market capitalisation of Alligo AB Series B is 6.2B SEK (≈ $624M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Alligo AB Series B (ALLIGO-B)?
The price-to-sales ratio of Alligo AB Series B is 0.63 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Alligo AB Series B (ALLIGO-B)?
Earnings per share at Alligo AB Series B are kr 6.86 (price ÷ EPS = P/E 17.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Alligo AB Series B (ALLIGO-B)?
The dividend yield of Alligo AB Series B is 1.8% (payout 26.7%, on adjusted earnings, reported 32.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Alligo AB Series B (ALLIGO-B)?
The net margin of Alligo AB Series B is 3.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Alligo AB Series B (ALLIGO-B)?
The return on equity (ROE) of Alligo AB Series B is 9.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Alligo AB Series B (ALLIGO-B)?
On an EBIT basis the return on assets of Alligo AB Series B is 6.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Alligo AB Series B (ALLIGO-B)?
The operating margin of Alligo AB Series B is 5.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Alligo AB Series B (ALLIGO-B)?
Revenue at Alligo AB Series B is growing +5.7% versus a year earlier (3y avg +1.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Alligo AB Series B (ALLIGO-B)?
Earnings per share at Alligo AB Series B are growing +130% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Alligo AB Series B (ALLIGO-B) carry?
The net debt of Alligo AB Series B is 4.0B SEK (fiscal year 2025, ≈ 5.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Alligo AB Series B in the live analysis
One click puts Alligo AB Series B on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Broad data
Oct 2, 2026